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The fungal pathogen Cryptococcus neoformans (Cn) is a serious threat to immunocom-
promised individuals, especially for HIV patients who develop meningoencephalitis. For
effective cryptococcal treatment, novel antifungal drugs or innovative combination thera-
pies are needed. Recently, sphingolipids have emerged as important bioactivemolecules in
the regulation of microbial pathogenesis. Previously we reported that the sphingolipid path-
way gene, ISC1, which is responsible for ceramide production, is a major virulence factor in
Cn infection. Here we report our studies of the role of ISC1 during genotoxic stress induced
by the antineoplastic hydroxyurea (HU) and methyl methanesulfonate (MMS), which affect
DNA replication and genome integrity. We observed that Cn cells lacking ISC1 are highly
sensitive to HU andMMS in a rich culturemedium. HU affected cell division ofCn cells lack-
ing the ISC1 gene, resulting in cell clusters. Cn ISC1, when expressed in a Saccharomyces
cerevisiae (Sc) strain lacking its own ISC1 gene, restored HU resistance. In macrophage-
like cells, although HU affected the proliferation of wild type (WT) Cn cells by 50% at the
concentration tested, HU completely inhibited Cn isc1 cell proliferation. Interestingly, our
preliminary data show that mice infected with WT or Cn isc1 cells and subsequently
treated with HU had longer lifespans than untreated, infected control mice. Our work sug-
gests that the sphingolipid pathway gene, ISC1, is a likely target for combination therapy
with traditional drugs such as HU.
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INTRODUCTION
Cryptococcus spp. are environmental fungal pathogens afﬂict-
ing immunocompromised patients as well as immunocompe-
tent individuals, causing life-threatening meningoencephalitis
(Idnurm et al., 2005; Jarvis et al., 2008; Dadachova and Casade-
vall, 2011; Del Poeta and Casadevall, 2011; Kronstad et al.,
2011; Kozubowski and Heitman, 2012). Cryptococcus causes
approximately one million annual cases of meningoencephali-
tis globally among AIDS patients, leading to nearly 625,000
deaths (Park et al., 2009). Despite major developments in HIV
treatment Cryptococcus infection still remains a major threat to
AIDS patients, especially in sub-Saharan Africa (Warkentien and
Crum-Cianﬂone, 2010).
Cryptococcus neoformans (Cn) is a ubiquitous fungus, found in
tree hollows andpigeondroppings. It is present in the environment
and in human hosts predominantly in the yeast form; however,Cn
can assume hyphal and other shapes depending upon its life cycle
state or environmental inﬂuences (Zaragoza et al., 2010; Kron-
stad et al., 2011; Kozubowski and Heitman, 2012). Pathogenic Cn
infection initiates upon the inhalation of infectious Cn particles,
which initially disseminate to the lungs and subsequently to the
central nervous system via the circulation if the host’s immune
response does not control fungal proliferation within the lung
(Kronstad et al., 2011). An intracellular facultative pathogen, Cn
can grow and replicate within the phagolysosome of phagocytic
cells, such as alveolar macrophages (AMs) and it can also grow
in extracellular spaces, such as within the alveoli or in the blood-
stream (Feldmesser et al., 2000; Goldman et al., 2000; Levitz, 2001;
Steenbergen et al., 2001; Shea et al., 2006). Because the pathogen
rapidly develops drug resistance (Morschhauser, 2010), and
because the number of immunocompromised patients is increas-
ing, there is a constant need for innovative and effective antifungal
therapies.
Hydroxyurea (HU), an antineoplastic drug used for treatment
of HIV, cancer, and myeloproliferative diseases (Kovacic, 2011)
slows the progression of DNA replication machinery by reducing
the cell’s deoxyribonucleotide (dNTP) pool (Katou et al., 2003).
HU treatment of the budding yeast Saccharomyces cerevisiae (Sc)
results in DNA replication fork slowing, and the formation of a
fork-protection complex to guard the cell’s replication machinery,
activating the replication checkpoint (Alcasabas et al., 2001; Katou
et al., 2003; Zegerman and Difﬂey, 2003; Bando et al., 2009). In
the absence of replication proteins, yeast cells become HU sen-
sitive. Interestingly, in addition to DNA replication genes, ∼300
genes from various other pathways have been shown to play role
in resistance to HU toxicity and the absence of these genes gives
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rise to HU sensitivity (Chang et al., 2002; Hartman and Tippery,
2004; Parsons et al., 2004; Woolstencroft et al., 2006).
Recently, lipid signaling, especially sphingolipid metabolism,
has gained recognition for its role in fungal pathogenesis (Shea
and Del Poeta, 2006; Rhome and Del Poeta, 2010; Singh and
Del Poeta, 2011). All yeast cells, including Cn, produce inositol-
containing sphingolipids instead of choline-containing sphin-
golipids (e.g., sphingomyelin), and the deletion of the inositol
sphingophospholipid phospholipase C 1 (ISC1) gene in Sc (Sc
isc1) causes accumulation of inositol-containing sphingolipids
(Sawai et al., 2000; Shea et al., 2006). Cn is a pathogenic yeast,
and deletion of ISC1 renders it incapable of causing menin-
goencephalitis (Shea et al., 2006). Isc1 has been characterized
in Sc (Sawai et al., 2000) and Cn (Henry et al., 2011) and in
Leishmania (Zhang et al., 2009), indicating that this sphingolipid
metabolizing enzyme has unique biochemical characteristics. The
absence of the ISC1 gene in Sc increases fungal sensitivity to HU
and methyl methanesulfonate (MMS) accompanied by cell divi-
sion arrest and morphological aberrations (Chang et al., 2002;
Matmati et al., 2009; Tripathi et al., 2011). Here, we report our
studies into the role of Cn ISC1 in the fungal resistance to HU and
MMS and their speciﬁc effects on the virulence of the pathogenic
fungus Cn. We show that Cn cells lacking the ISC1 gene are highly
sensitive to HU and MMS and form cell clusters upon HU expo-
sure. The absence of ISC1 in conjunction with HU treatment
synergistically reduced Cn infection of macrophage-like cells and
immunocompetent mice.
MATERIALS AND METHODS
STRAINS AND PLASMIDS
Wild type (WT) Cn (var. grubii serotype A strain H99) and its
isc1 derivative were used in the current study and have been
described previously (Shea et al., 2006; Henry et al., 2011). The
Sc strain Jk9-3d a (MATa trp1 leu2-3 his4 ura3 ade2 rme1) and
its isc1 derivative were used and have been described previously
(Matmati et al., 2009; Tripathi et al., 2011).
EXPOSURE TO HU AND MMS
YPD plates (1% yeast extract, 2% peptone, and 2% glucose plus
2% agar) containing appropriate concentrations of HU (Sigma; 0,
25, 50, 100, and 200mM) orMMS (Sigma; 0.033%)were prepared
and used within 48 h. Overnight cultures were inoculated in fresh
medium atA600 of 0.2 and grown at 30◦C. Log-phase cultures were
adjusted to A600 of 0.4 before making 10-fold serial dilutions and
plate spotting (2.5μl). Plasmids pYES-Sc ISC1 and pYES-Cn ISC1
that express Sc ISC1 and Cn ISC1 genes respectively have been
described previously (Henry et al., 2011). The two plasmids and a
control vector were transformed into appropriate strains (WT and
isc1 of Sc) and plated on SD/Ura− plates. Then, 10-fold serial
dilutions of log-phase liquid cultures in SD/Ura− liquid medium
were spotted on SD/Ura− and SD/Ura−/HU plates, and the plates
were incubated at 30◦C, and analyzed at appropriate times before
recording the data.
CELLULAR MORPHOLOGY
Cells were grown to log-phase as described above, HU (25–
200 mM) or MMS (0.033% v/v) was added, and cells were
incubated for 5 or 22 h before they were ﬁxed with 3.7% formalde-
hyde. Cells were washed with phosphate buffered saline (PBS,
50mM,pH7) and further suspended inPBSbefore analyzing them
under a Nikon Eclipse (TE2000-5) microscope with a 40×/100×
objective lens.
EFFECT OF HU ON INTRACELLULAR GROWTH OF Cn
The murine reticulum sarcoma macrophage-like cell line J774A.1
cells were used up to passage #8. Cells were then plated in 96-
well cell culture plates in Dulbecco’s minimal essential medium
supplemented with 10% fetal bovine serum. WT Cn (H99) and
its isc1 derivative were grown overnight in YPD at 30◦C. Cells
were washed three times in PBS and counted. Approximately 105
cells in DMEM + FBS medium were added with 10 μg/ml of
anti-GXM monoclonal antibody 18B7 (kindly provided by Dr.
Arturo Casadevall) with 1 mM HU or without HU. Meanwhile
the macrophage-like cells were washed off the non-adhered cells
and activated with 50 units/ml of recombinant murine gamma
interferon (IFNγ) and 0.3μg/ml of lipopolysaccharide (LPS). The
antibody-opsonized Cn cells were added to the macrophage cells
at an effector-to-target ratio of 1:1. After incubation for 2 h, extra-
cellular Cn cells were washed with three changes of warm DMEM
medium and fresh medium without or with 1 mM of HU. For
one set of the experiments 200 μl sterile water was added to each
well and the macrophage-like cells were lysed by pipetting sev-
eral times. The samples were diluted and an aliquot was spread
on YPD agar plate for determining colony forming units (CFUs);
this set served as the time-point “zero.” The other time points
were 6, 12, and 24 h, at which points the supernatant was aspi-
rated and cells were rinsed once with DMEM. Macrophage cells
were lysed by adding 200 μl of sterile water and pipetting several
times. The samples were diluted and spread on YPD agar plate for
determining the CFUs.
For the phagocytic indices (PI) and for photographs, the con-
ditions were same as above except that the macrophage-like cells
were grown on glass cover slips. After 2 h of the Cn challenge,
the cells were washed three times with PBS, ﬁxed with ice-cold
methanol, and stained with Giemsa. For the 24-h experiment,
cells were washed three times and fresh medium without HU or
with 1 mM HU was added and incubated at 37◦C in 5% CO2.
After 24 h the cells were washed three times with PBS, ﬁxed with
ice-cold methanol, and stained with Giemsa. Photographs were
taken using a Zeiss microscope equipped with charged-coupled
device camera. Results for 0 and 24 h time points are shown in
the text.
SURVIVAL STUDIES IN MOUSE MODELS
Mice were anesthetized with a xylazine–ketamine mixture (60 μl,
i.p., 5 mg/kg xylazine, 95 mg/kg ketamine). All Cn strains were
grown in YPD medium for 16–18 h at 30◦C. Cells were washed
and re-suspended in PBS. Mice were challenged intranasally with
20 μl of the inoculum containing 5 × 105 Cn cells. After Cn
infection, mice were administered HU (0.8 mg/kg every 48 h).
Mice were fed ad libitum and monitored twice daily for signs of
morbidity or pain or clinical signs suggesting meningoencephali-
tis. Mice exhibiting any of these signs were immediately sacriﬁced
using CO2 inhalation followed by cervical dislocation.
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STATISTICAL ANALYSIS
All data were analyzed by standard Student’s t-test with P values
shown in appropriate ﬁgures.
RESULTS
ABSENCE OF ISC1 CAUSES SENSITIVITY TO HU AND MMS IN Cn CELLS
Cryptococcus neoformans WT and isc1 cells were analyzed for
their response to long-term exposure to HU and MMS. As shown
in Figures 1A,B, whereas WT Cn cells recovered from HU and
MMS stress, isc1 cells were highly sensitive to both HU and
MMS. The HU sensitivity of Cn isc1 cells was almost compa-
rable to that of Sc isc1 cells (Figure 1A). To ensure that the
sensitivity to HU and MMS was due to loss of the ISC1 gene, we
examined a Cn isc1 strain containing reconstituted ISC1 for HU
and MMS tolerance. As shown in Figures 1A,B, the reconstituted
strain was resistant to HU and MMS similar to the WT strain,
strongly suggesting a role for Cn ISC1 in HU/MMS tolerance. In
addition to testing the role of the reconstituted strain for HU and
MMS sensitivity, we tested the role of Cn ISC1 in HU tolerance
independently: we expressed theCn ISC1 gene in an Sc isc1 strain
and examined whether the former complemented HU sensitivity.
As shown in Figure 1C, whereas the Sc WT strain containing a
vector showed HU resistance, its isc1 derivative containing the
vector was HU sensitive. In contrast, the Sc isc1 strain express-
ing either Sc ISC1 or Cn ISC1 (in pYES vector; Henry et al., 2011)
showed HU resistance, albeit with minor differences (Figure 1C).
All these results show that Cn Isc1 plays a key role in HU/MMS
tolerance.
ABSENCE OF ISC1 AFFECTS CELL MORPHOLOGY AND CELL DIVISION
IN Cn CELLS UPON EXPOSURE TO HU AND MMS
We examined whether Cn ISC1 controls cell division and cellu-
lar morphology under HU stress. Cn WT and isc1 cells were
grown in the presence of various concentrations of HU in liq-
uid media and cell morphology was analyzed microscopically.
As shown in Figures 2A,B, HU did not affect cell division of
WT cells at 25–50 mM concentrations; however, the bud size
was relatively large compared to the untreated WT cells. At
higher concentrations of HU (100–200 mM) some WT cells
had defects in cell division resulting in cell chains. In con-
trast to the WT cells, cell division in isc1 cells was severely
inhibited at low HU concentrations (25–50 mM) resulting in
cell chains and lawns (Figures 2A,B); a few misshapen cells
were also seen (data not shown). These data suggest a syner-
gism between HU and the absence of ISC1 in inhibiting cell
division.
SYNERGISTIC EFFECTS OF HU AND ISC1 DELETION ON
MACROPHAGE INFECTION
One mechanism by which Isc1 protects Cn cells against the host
immune response is by increasing the resistance to antifungal
activity of macrophages by favoring fungal intracellular growth
(Shea et al., 2006). HU treatment of macrophages infected by Tox-
oplasma gondii, Leishmania amazonensis, Trypanosoma cruzi, and
L. mexicana has been shown to drastically reduce the number
of infected cells (Melo and Beiral, 2003; Martinez-Rojano et al.,
2008). Therefore, we tested whether HU would compromise the
FIGURE 1 | Cryptococcus neoformans cells lacking the ISC1 gene are
sensitive to HU and MMS. (A)Ten-fold serial dilutions of log-phase
cultures of C. neoformans (WT, isc1, and isc1 + Cn ISC1 reconstituted)
and S. cerevisiae (WT and isc1 strains) were spotted on plates containing
YPD andYPD + HU (50 mM). (B)Ten-fold serial dilutions of log-phase
cultures of C. neoformans (WT, isc1, and isc1 + Cn ISC1 reconstituted)
were spotted onYPD andYPD + 0.033% MMS plates. (C) Cn ISC1
complements HU sensitivity of the S. cerevisiae isc1 strain. Ten-fold serial
dilutions of following log-phase cultures were spotted on SD/Ura− and
SD/Ura−/HU plates: Sc WT cells containing pYES vector, Sc isc1 cells
containing the pYES vector, Sc isc1 cells containing pYES-Sc ISC1 and Sc
isc1 cells containing pYES-Cn ISC1.
intracellular growth of Cn cells. We ﬁrst allowed macrophages to
internalize Cn cells and then treated the macrophages with HU.
HU treatment diminished the intracellular growth of WT Cn by
∼3.5-fold (Figure 3A). Interestingly, HU treatment completely
abolished the growth of Cn isc1 cells within the macrophages
suggesting a strong synergism between HU and ISC1 deletion.
Representative macrophages with Cn infection are shown in
Figure 3B. Importantly, inhibition of intracellular growth was
not due to HU’s effect on phagocytosis because the drug did
not inhibit macrophage ingestion of Cn (data not shown). We
have already demonstrated that a Cn isc1 strain reconstituted
with Cn ISC1 behaves like the WT Cn strain in macrophages
(Shea et al., 2006). Because the in vitro experiments were car-
ried out at 30◦C and in vivo experiments were performed at
37◦C, we needed to ensure that the loss of isc1 cell viability
in macrophages was not temperature dependent. Thus, we grew
WT and isc1 cells at 37◦C and compared these data with those
obtained at 30◦C. We observed that the growth pattern of WT
and isc1 at 37◦C was similar to those patterns observed at 30◦C
(data not shown).
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FIGURE 2 | Cryptococcus neoformans cells show HU-induced defects
in morphology and cell division. (A) Cn WT and isc1 cells were treated
with HU overnight and observed under phase contrast microscope
(×1000). Cn isc1 cells formed cell chains and clumps upon HU exposure.
(B) Bar diagrams showing morphological aberrations in untreated and
HU-treated Cn WT and Cn isc1 cells.
HU TREATMENT INHIBITS GROWTH OF Cn WT AND isc1
CELLS IN MICE
We tested the effects of HU on survival and virulence of Cn WT
and isc1 strains in mice. Mice were infected with fungal cells and
treated with HU as described in Section “Materials andMethods.”
Interestingly, HU inhibited the proliferation of WT Cn cells in
mice and signiﬁcantly prolonged their survival. In addition, we
observed that HU acted synergistically when the ISC1 gene was
absent to inhibit Cn cell growth. We performed survival and tis-
sue burden studies in mice by infecting them intranasally with
Cn WT or the isc1 strain and then treated the mice with HU
(0.8 mg/kg every other day). As expected, untreated mice died
within 30 days whereas HU-treated mice survived up to 60 days
(Figure 4A). Interestingly, mice infected with Cn isc1 cells also
survived for 60 days regardless of HU treatment (Figure 4B). HU
signiﬁcantly reduced fungal burden, especially in the lung tissue.
Speciﬁcally, HU-treatment reduced the number of CFUs in the
lung infected with Cn WT by ∼10-fold from the initial inoculum
(Figure 4C). Remarkably the number of Cn isc1 CFU decreased
by ∼1,700 fold in HU-treated mice compared to untreated mice.
These data suggest a synergistic effect of HU treatment with ISC1
deletion in increasing host survival by decreasing organ fungal
load. The survival of mice infected with WT Cn and treated with
HU suggests that exposure toHU (at theHU concentration tested)
slows downDNA replication and growth of WT cells, allowing the
host’s immunity to take over the pathogen. The role of Cn ISC1 in
mice experiments was revealed by the CFU of HU-treatedWT Cn,
untreated isc1 and HU-treated isc1 cells recovered from lung
tissues.
DISCUSSION
Our results show that HU slows down growth of WT Cn cells,
which helps both mice and macrophages to inhibit further
pathogenic growth. This effect is enhanced by deletion of ISC1,
suggesting that Isc1 and the sphingolipid metabolic pathway in
general should be exploited as novel targets for antifungal drug
development, either alone or in combination with existing drugs
(e.g., HU) to better control cryptococcosis. Of note, all experi-
ments conducted with mice ended on the 60th day of infection
when all surviving mice were sacriﬁced. Thus, we observed no
differences in survival between WT and isc1 cells upon HU
treatment; the isc1 has a signiﬁcant defect in virulence. How-
ever, treatment with HU profoundly diminished Cn proliferation
in the lung environment compared to untreated cells.
At present, the molecular mechanism of HU inhibition of Cn
growth is unknown. We hypothesize that isc1may be more sus-
ceptible than the WT strain because it controls phytoceramide
generation (Garcia et al., 2008) and its decrease in the deletion
mutant could affect membrane permeability and thus HU trans-
port. However, this hypothesis was not supported by studies in
budding yeast in which the inhibition of DNA synthesis by HU
was not enhanced by deletion of ISC1 (Matmati et al., 2009).
Of note, HU has been shown to have an anti-proliferative activ-
ity on T cells (Benito et al., 2007) and to cause neutropenia in
humans and mice (Hermans et al., 1999). Because neutropenia is
associated with prolonged survival of Cn-infected mice (Mednick
et al., 2003)HU could increasemice survival through neutropenia.
However, the neutropenic effect of HU is remarkably linked to the
administered HU dose. Almost all patients will develop neutrope-
nia when the administered dose is 20–30 mg/kg/day or greater.
However, several studies have shown that such toxicity can be dra-
matically reduced if the HU dose is decreased to 4–5 mg/kg/day.
In mice, HU at 50 mg/kg/day in a sickle cell model does cause
a moderate neutropenia, whereas a lower dose of 25 mg/kg/day
does not cause neutropenia (Lebensburger et al., 2012). The dose
used in our mouse experiment was 0.8 mg/kg/every other day, a
dose that is 10-fold less that the HU dose that does not produce
neutropenia in people and 25- to 50-fold less than the dose that
does not produce neutropenia in mice. Thus, due to the very low
dose of HU used in our experimentations, we hypothesize that
the increased mouse survival is not due to an effect of HU on
neutrophils.
We predict that HU (at the concentration tested here) slows Cn
DNA replication and cell division while host immunity overtakes
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FIGURE 3 | Synergistic role of HU and ISC1 deletion on Cryptococcus
infection of the macrophage-like cell line J774A.1. (A) Phagocytosis assay
with macrophage-like cell line J774A.1 cells infected with Cn WT or isc1
cells in the presence/absence of HU (see Materials and Methods). (B) Cn
cells phagocytosed by J774A.1 were grown in the presence/absence of HU
and stained with Giemsa after 24 h. Photographs were taken with a Zeiss
microscope equipped with a CCD camera. All images were captured
under oil immersion (×100). Red arrows indicate the presence/absence
of Cryptococcus in the phagolysosomes of macrophages. Most
phagolysosomes in untreatedWT cells contained Cn cells, whereas some
HU-treatedWT cells still contained Cn cells. In contrast, most macrophages
did not contain Cn isc1 cells regardless of HU treatment.
the pathogen. This effect appears to be enhanced when Cn cells
are intracellular. This hypothesis is supported by our experiment
with macrophage-like cell line showing that HU signiﬁcantly sup-
presses fungal cell divisionwithinmacrophages. Very interestingly,
HU has been tested against various intracellular parasites such
as Toxoplasma gondii, L. amazonensis, Trypanosoma cruzi, and L.
mexicana (Melo and Beiral, 2003; Martinez-Rojano et al., 2008).
Not only did HU inducemorphological changes in these parasites,
but also it inhibited intracellular multiplication of these microbes,
similar to the phenotype observed with Cn in macrophages illus-
trated in this paper. In addition, in L. mexicana HU induced cell
cycle arrest suggesting that the mechanism by which HU inhibits
the synthesis of the DNA replication and cell division has been
maintained in different microbial species.
A recent study points to an important aspect concerning the
use of HU to control cryptococcosis. The authors found that
HU enhances post-fusion hyphal extension in Cn cells, but not
in haploid cells (Zulkiﬂi et al., 2012). HU is known to induce mor-
phological changes such as hyphal generation in Candida albicans
(Shi et al., 2007; Sun et al., 2011) but in Sc it generates limited
morphological aberrations (in 1–3% cells) and extensivemorpho-
logical aberrations are seen in Sc mutants on checkpoint, budding
and, notably, in the isc1 deletion mutant (Jiang and Kang, 2003;
Enserink et al., 2006; Tripathi et al., 2011). It seems thatCn behaves
similar to Sc; morphological changes by HU (at low concentra-
tions) only occur in isc1 cells and not in WT cells. In another
study it has been shown that certain Cn mutants such as ras1
were sensitive to HU and MMS (Maeng et al., 2010).
Intriguingly, the morphological changes ascribed to HU are
strictly linked to defects in yeast cell division. Possibly, in addi-
tion to the inhibition of DNA synthesis, HU also affects actin
polymerization/depolymerization during Cn cell division and
cell wall synthesis (Enserink et al., 2006; Tripathi et al., 2011).
This hypothesis is supported by our previous studies in Sc in
which we showed that actin depolymerization is inhibited by
HU especially in conditions in which ISC1 is deleted. This
will ultimately block cell division or cell proliferation (Tripathi
et al., 2011), possibly through the regulation of morphogenesis
and DNA integrity checkpoint proteins. The latter hypothesis is
also supported by the results presented in this paper in which
we show that HU delays the separation of Cn isc1 daugh-
ter cells from the mother cell (Figures 2A,B). This delay in
cell division of Cn cells may expose the isc1 cells for longer
time to intracellular inhibitors (e.g., hydrogen peroxide, nitric
oxide) rendering isc1 even more susceptible to the intracel-
lular compared to the extracellular environment. Considering
that the Cn isc1 is already hypersusceptible to hydrogen per-
oxide and nitric oxide (Shea et al., 2006), the treatment with HU
may render the isc1 cells even more sensitive than WT cells.
Thus, it is possible that HU does increase the killing capacity
of macrophages indirectly by increasing the exposure of undi-
vided Cn cells to intracellular toxins. Finally, in Sc HU affects
chitin deposition on the cell wall (Tripathi et al., 2011) partic-
ularly when ISC1 is deleted. This observation further supports
a role for Isc1 under HU stress in cell division as chitin is an
important regulator of cell morphology and cell division in yeasts
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FIGURE 4 | Role of HU and ISC1 deletion on the survival of mice
and on lung tissue burden. (A) Survival curve of CBA/J mice upon
infection withWT Cn in the presence (green) or absence (black) of HU;
(B) Survival curve of CBA/J mice upon infection with Cn isc1 cells
in the presence (red) or absence (blue) of HU. (C) Survival of Cn cells
in lung tissue of CBA/J mice after 60 days of infection. Lung tissues
were collected from mice and Cn CFU was counted by plating on
YPD plates.
(Roh et al., 2002). These are exciting possibilities that we will
explore in the future.
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